Seeing Is Believing
Currently out of the existing stock ratings of Edward White, 372 are a BUY (96.88%), 11 are a HOLD (2.86%), 1 are a SELL (0.26%).
Analyst Edward White, carries an average stock price target met ratio of 27.32% that have a potential upside of 52.53% achieved within 130 days. Previously, Edward White worked at HC WAINWRIGHT.
Edward White’s has documented 780 price targets and ratings displayed on 37 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on IKT, Inhibikase Therapeutics at 28-Mar-2025.
Analyst best performing recommendations are on SBTX (SILVERBACK THERAPEUTICS ).
The best stock recommendation documented was for MRTX (MIRATI THER) at 11/15/2017. The price target of $17 was fulfilled within 1 day with a profit of $2.95 (21%) receiving and performance score of 209.96.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$4.25
$-0.09 (-2.07%)
$4.25
4 months 22 days ago
(08-Nov-2024)
1/5 (20%)
$-0.11 (-2.52%)
148
Buy
$13
$8.66 (199.54%)
7 months 28 days ago
(02-Aug-2024)
0/1 (0%)
$11.13 (595.19%)
Buy
$10
$5.66 (130.41%)
$10
1 years 7 months 8 days ago
(22-Aug-2023)
1/4 (25%)
$7.03 (236.70%)
28
Hold
$7
$2.66 (61.29%)
$7
2 years 3 months 22 days ago
(08-Dec-2022)
2/4 (50%)
$2.8 (66.67%)
79
Buy
$26
2 years 4 months 16 days ago
(14-Nov-2022)
2/5 (40%)
$17.95 (222.98%)
182
Which stock is Edward White is most bullish on?
Which stock is Edward White is most reserved on?
What Year was the first public recommendation made by Edward White?